Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Poschner, T; Werner, P; Kocher, A; Laufer, G; Musumeci, F; Andreas, M; Russo, M.
The JenaValve pericardial transcatheter aortic valve replacement system to treat aortic valve disease
FUTUR CARDIOL. 2021; 18(2): Doi: 10.2217/fca-2021-0065
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz
Andreas Martin
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Transcatheter aortic valve replacement is a valuable alternative technique to surgery and the spectrum of therapy continues to evolve. The JenaValve Pericaridal transcatheter aortic valve replacement System allows prosthesis fixation in a native, noncalcified aortic annulus with a unique paper clip-like anchorage mechanism. The low rate of paravalvular leakage and permanent pacemaker implantation emphasizes the further widespread use of the JenaValve - despite the limited data available. In May 2021, a CE mark for the transfemoral implantation in both aortic regurgitation and aortic stenosis was granted. However, no data have been published so far. The ongoing ALIGN trials are expected to provide the pending long-term data.

Find related publications in this database (Keywords)
aortic regurgitation
aortic stenosis
cardiac surgery
interventional cardiology
leaflet thrombosis
pacemaker
paravalvular leakage
TAVR
valve-in-valve
© Med Uni GrazImprint